SEC Form 4 · accession 0001179110-15-011213
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth Stoner
Director
Period of report
Jul 15, 2015
Accepted (ET)
Jul 16, 2015 · 2:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2015 | M | 1,667 | $6.79 | A | 12,810 | D | |
| Common Stock | Jul 15, 2015 | S | 1,086 | $22.35 | D | 11,724 | D | |
| Common Stock | Jul 15, 2015 | M | 5,000 | $8.85 | A | 16,724 | D | |
| Common Stock | Jul 15, 2015 | S | 3,484 | $22.35 | D | 13,240 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.79 | Jul 15, 2015 | M | 1,667 | D | Dec 14, 2008 | Dec 14, 2017 | Common Stock | 1,667 | 0 | D |
| Stock Option (Right to Buy) | $8.85 | Jul 15, 2015 | M | 5,000 | D | Jun 11, 2010 | Jun 11, 2019 | Common Stock | 5,000 | 10,000 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2015.